scholarly journals P112. Effectiveness of "Hospital Anxiety and Depression Scale" for the screening of the psychiatric treatment need in outpatients with Inflammatory Bowel Diseases

2015 ◽  
Vol 9 (suppl 1) ◽  
pp. S132-S132 ◽  
2013 ◽  
Author(s):  
Ηλίας Βλάχος

Objective – To investigate the hypothesis that depression and anxiety levelscould beassociatedwith theinduction of theantiapoptoticHeatShock Protein70 (HSP70) inthe colon of patients with Inflammatory Bowel Diseases (IBD),namelyulcerativecolitis(UC)andCrohn‟sdisease(CD).Methods- 54 consecutive, hospitalized IBD patients in relapse gave theirinformed consent, filled out psychometric questionnaires [Zung DepressionRatingScale(ZDRS),SpielbergerState-TraitAnxietyInventory(STAIFormXI,IIas a state andas a trait), Hospital Anxiety and Depression Scale (HADS)].Simultaneously, intestinal biopsies were taken to be diagnosed in a blindedmanner by two pathologists. The type and severity of inflammation wereassessedoneachsection withhematoxylin/eosinstaining.Thelocalizationandintensity of expression ofHSP70 expression were studiedimmunohistochemically.Results:31/54patientssufferedfromactiveUC,14fromCDand9wereinremission.InducibleHSP70(HSP70i)wasscarcelydetectableintheintestinalmucosa of UC and CD patients. There was statistically significant correlationbetween depression and anxiety levels and inducible HSP70 in thepolymorphonuclearcells(PMN)ofpatientswithactiveUC.Conclusion: Inducible HSP70 is clearly expressed in PMN cells of IBD patientsand in patients with active UC this finding positively correlates with thedepression and anxiety levels. Given the antiapoptotic, cytoprotective effect ofHSP70onPMNcells and thedestructiverole thatPMNcellsexertonintestinalmucosa of IBD patients, light could be shed on the psychosomatic aspect ofautoimmunityinthesediseases.


2021 ◽  
pp. 42-46
Author(s):  
V. E. Bandel ◽  
E. I. Mikhailova

Objective. To study the quality of life (QoL) and psycho-emotional state in patients with different degrees of ulcerative colitis (UC) activity.Materials and methods. The study involved 52 patients with UC and 52 healthy volunteers (HVs). The survey was performed using the questionnaire IBDQ, assessing the quality of life in patients with inflammatory bowel diseases, the Hospital Anxiety and Depression Scale (HADS), and the questionnaire by A.M. Vein.Results. The patients with UC in comparison with the HVs have a lower QoL in the overall score (p < 0.05), a greater severity of psychological problems both according to the anxiety scale (p < 0.05) and to the depression scale (p < 0.05).), and they tend to develop the autonomic dysfunction syndrome more often (p < 0.05).Conclusion. The method of the QoL assessment and psycho-emotional state in patients with UC provides accurate scientifc information about the physical, psychological, emotional and social status of the patients.


2021 ◽  
Vol 10 (15) ◽  
pp. 3270
Author(s):  
Lorenzo Bertani ◽  
Brigida Barberio ◽  
Domenico Tricò ◽  
Federico Zanzi ◽  
Daria Maniero ◽  
...  

During the coronavirus disease 2019 (COVID-19) pandemic, immunomodulatory therapies and hospital admission were suspected to increase the risk of infection. Nevertheless, patients with inflammatory bowel diseases (IBD) treated with intravenous (i.v.) biologics had to move to hospitals for drug infusion. We investigated the impact of hospitalisation in patients with IBD. We conducted a survey including consecutive IBD patients initially in clinical and biochemical remission treated with biologics at the end of the first lockdown period. Patients underwent the normally scheduled clinical visits, performed at hospital for i.v.-treated patients or at home for patients treated with s.c. drugs. We administered to all patients the Hospital Anxiety and Depression Scale (HADS) questionnaire and other 12 questions, specifically related to COVID-19 and its implications. A total of 189 IBD patients were recruited, 112 (59.3%) treated with i.v. drugs and 77 (40.7%) with s.c. ones. No relapses were recorded in either group (hospitalized vs. non-hospitalized, p = ns), as well as which, COVID-19 infections were not demonstrated in patients in contact with people with suspected symptoms or directly experiencing them. The total HADS score obtained by the sum of all items was also almost identical between groups (37.1 ± 2.8 vs. 37.2 ± 2.8; p = 0.98). In patients treated with i.v. drugs receiving a televisit (n = 17), the rate of satisfaction with telemedicine (58.8%) was significantly lower compared with those treated with s.c. drugs (94.8%; p < 0.0005). Our results suggest that hospitalisation during the COVID-19 outbreak does not increase the risk of COVID-19 infection as well as the risk of IBD relapse; moreover, the similar levels of anxiety in both groups could confirm that there is no need to convert patients from i.v. to s.c. therapy.


2018 ◽  
Vol 26 (5) ◽  
pp. 508-513 ◽  
Author(s):  
Philip Keightley ◽  
Rebecca E Reay ◽  
Paul Pavli ◽  
Jeffrey CL Looi

Objectives: Fatigue is a common and disabling problem in inflammatory bowel disease. We sought to explore the possible determinants of inflammatory bowel disease-associated fatigue including demographic, psychological and disease variables. Methods: Surveys were distributed to 100 patients undergoing infliximab infusion for inflammatory bowel disease in an infusion lounge, assessing attachment style (Experiences in Close Relationships Revised scale), fatigue (Functional Assessment of Chronic Illness Therapy Fatigue – Fatigue Subscore), and depression and anxiety (Hospital Anxiety and Depression Scale). Disease severity was assessed via file review through an independent gastroenterologist rating (Harvey–Bradshaw Index). Results: There were 67 responses. Depression, as measured by the Hospital Anxiety and Depression Scale, was found to be highly correlated with fatigue (Functional Assessment of Chronic Illness Therapy Fatigue – Fatigue Subscore). Anxiety, insecure attachment, disease severity and female gender were moderately correlated with fatigue. In a hierarchical regression model, depression and female gender emerged as significant predictors of variance in fatigue scores. Conclusions: Depression was the strongest predictor of variance in fatigue scores. Gender as a cause of fatigue in inflammatory bowel disease requires further exploration. Attachment style, however, may still help clinicians to conceptualise help-seeking behaviour and clinician-patient relationships in medically unexplained symptoms.


2017 ◽  
Vol 41 (S1) ◽  
pp. S320-S320
Author(s):  
F. Travagliati ◽  
E. Borrelli ◽  
S. Martinelli ◽  
L. Dattoli ◽  
D. Ferrarese ◽  
...  

IntroductionInflammatory bowel diseases (IBDs) have high social impact. Aetiology is still unknown, however multifactorial genesis is surely implicated. We tried to correlate IBDs and psychological distress through evaluated psychometrical instruments and subsequently to relate subjective influences with gastroenteric clinical manifestation, defining new critical elements on which IBD are based.MethodsIn our study, we included 57 participants, selected according to their diagnosis, between those attending our gastrointestinal ambulatory: 26 had Chron's disease, while 31 had ulcerative colitis. 78 people without gastroenteric or psychiatric disorder were also included in the study as control group. Psychometric questionnaires were administered to evaluate anxiety and depressive symptoms, quality of live, self-efficacy and resilience (Fig. 1).ResultsLevels of anxiety and depression were higher in patients with IBDs than in the control group. STAI-Y highlighted higher state anxiety and trait anxiety levels in first group. HADS showed higher scores in ill patients, as well as CD-RISC showed a more impaired resilience. EQ-VAS, PGWBI and GSE revealed significant differences in health status, psychological wellness and self-efficacy between the two groups.ConclusionsIBDs seem related to psychological diseases. Affected patients have higher anxiety and depression levels than general population as well as lower self-efficacy and resilience. Those elements being strictly linked to physical discomfort contributes to develop a loop in which patients get caught. Creating a model of integrated cooperation between gastroenterologist and psychiatrist during treatment of patients with IBDs seems fundamental to grant at once all the professional figures each patient needs for better care.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Sign in / Sign up

Export Citation Format

Share Document